TapewireFind a company

person · Reporting owner

Avelar Rui

Disclosed activity across 1 company

Tapewire entity
56823
SEC CIK
0001432063

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Evolus, Inc.EOLS · Entity 5341See RemarksMarch 20, 2026March 20, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Evolus, Inc.

Report date March 20, 2026 · Filed March 20, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect427,423 Reported balance After 2026-03-20 transaction · row 1
1 source row

Row 1 · 2026-03-20 · Sale · Disposed 3,119 · Balance 427,423

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards.

F2: The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing footnotes · ownership attribution and instrument terms

F1: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards.

F2: The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 20, 2026 Filed Mar 20, 2026 23:19 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 3,119 $4.75 $14,815.25
Disclosure

SEC source: 0001570562-26-000050 · wk-form4_1774048743.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 427,423

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the settlement of restricted stock unit awards.

F2 · price: The shares were sold in multiple trades at prices ranging from $4.7498 to $4.7701. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 17, 2026 Filed Mar 19, 2026 00:00 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 29,996 $4.89 $146,629.45
Disclosure

SEC source: 0001570562-26-000045 · wk-form4_1773878429.xml · nonDerivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 430,542

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of multiple PSU and restricted stock unit awards.

F3 · price: The shares were sold in multiple trades at prices ranging from $4.8874 to $4.945. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 16, 2026 Filed Mar 19, 2026 00:00 UTC Evolus, Inc. EOLS · Entity 5341 Exercise / conversionPerformance Restricted Stock Units · Derivative 8,804 $0.00 $0.00
Disclosure

SEC source: 0001570562-26-000045 · wk-form4_1773878429.xml · derivative · entry 3

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 8,802

Underlying: Common Stock · 8,804 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures.

F1 · kind: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures.

F1 · derivative.exercise_date: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures.

F1 · derivative.expiration_date: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures.

Read SEC document
March 16, 2026 Filed Mar 19, 2026 00:00 UTC Evolus, Inc. EOLS · Entity 5341 Exercise / conversionCommon Stock 8,804 $0.00 $0.00
Disclosure

SEC source: 0001570562-26-000045 · wk-form4_1773878429.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 460,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: As previously reported, on February 7, 2024, the Reporting Person was granted 17,606 performance restricted stock units ("PSUs") at target pursuant to the Evolus, Inc. 2017 Omnibus Incentive Plan. The PSUs were subject to performance conditions based on certain pre-specified revenue and defined non-GAAP operating profit measured over the Issuer's 2024 and 2025 fiscal years. The Compensation Committee certified achievement at 100% of target, resulting in 17,606 earned PSUs. Of the earned PSUs, 50% vested and settled on March 16, 2026, resulting in the issuance of 8,804 shares of the Issuer's common stock. The remaining 8,802 PSUs remain outstanding and are scheduled to vest on February 7, 2027, subject to continued service. The number of shares reported reflects rounding adjustments applied in accordance with the terms of the award and administrative procedures.

Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:57 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 138,649 $0.00 Strike: $4.39 $0.00
Disclosure

SEC source: 0001570562-26-000021 · wk-form4_1771552634.xml · derivative · entry 3

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 138,649

Underlying: Common Stock · 138,649 shares

Expires 2036-02-17

F4 · derivative.exercise_date: The shares subject to the option vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control).

Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:57 UTC Evolus, Inc. EOLS · Entity 5341 GrantPerformance Restricted Stock Units · Derivative 94,913 $0.00 $0.00
Disclosure

SEC source: 0001570562-26-000021 · wk-form4_1771552634.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,913

Underlying: Common Stock · 94,913 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs.

F3 · derivative.exercise_date: The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period.

F3 · derivative.expiration_date: The number of shares issuable upon vesting is based on performance against pre-established financial metrics and relative total shareholder return (TSR) over a three-year performance period ending December 31, 2028. Subject to certification of performance results, any earned PSUs vest following the performance period.

Read SEC document
February 17, 2026 Filed Feb 20, 2026 01:57 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 94,913 $0.00 $0.00
Disclosure

SEC source: 0001570562-26-000021 · wk-form4_1771552634.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 451,734

F1 · shares: Represents shares issuable upon settlement of restricted stock units (RSUs). Each RSU represents the right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments on each anniversary of February 17, 2026, subject to continued service, and may accelerate in certain circumstances (including specified terminations or a change in control).

Read SEC document
December 22, 2025 Filed Dec 29, 2025 23:42 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 2,261 $7.15 $16,167.73
Disclosure

SEC source: 0001570562-25-000118 · wk-form4_1767051717.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 356,821

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units.

Read SEC document
May 12, 2025 Filed May 14, 2025 23:27 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 3,385 $9.87 $33,396.75
Disclosure

SEC source: 0001570562-25-000081 · wk-form4_1747265264.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 359,082

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain restricted stock units.

Read SEC document
March 18, 2025 Filed Mar 20, 2025 22:27 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 27,904 $13.26 $369,867.52
Disclosure

SEC source: 0001570562-25-000054 · wk-form4_1742509649.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 362,467

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $13.174 to $13.256. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 22:54 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 33,875 $0.00 Strike: $13.58 $0.00
Disclosure

SEC source: 0001570562-25-000041 · wk-form4_1741733665.xml · derivative · entry 3

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 33,875

Underlying: Common Stock · 33,875 shares

Expires 2035-03-07

F4 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 22:54 UTC Evolus, Inc. EOLS · Entity 5341 GrantPerformance Restricted Stock Units · Derivative 23,776 $0.00 $0.00
Disclosure

SEC source: 0001570562-25-000041 · wk-form4_1741733665.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,776

Underlying: Common Stock · 23,776 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs.

F3 · derivative.exercise_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 100% of the PSUs will vest on March 7, 2028 in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

F3 · derivative.expiration_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 100% of the PSUs will vest on March 7, 2028 in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

Read SEC document
March 07, 2025 Filed Mar 11, 2025 22:54 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 23,776 $0.00 $0.00
Disclosure

SEC source: 0001570562-25-000041 · wk-form4_1741733665.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 390,371

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of March 7, 2025, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
December 23, 2024 Filed Dec 26, 2024 22:28 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 2,252 $10.85 $24,438.48
Disclosure

SEC source: 0001570562-24-000140 · wk-form4_1735252102.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 366,595

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units.

Read SEC document
May 10, 2024 Filed May 15, 2024 00:56 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 3,441 $12.72 $43,760.57
Disclosure

SEC source: 0001570562-24-000085 · wk-form4_1715734552.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 368,847

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale occurred automatically to satisfy the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · price: The shares were sold in multiple trades at prices ranging from $12.51 to $13.06. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
March 19, 2024 Filed Mar 21, 2024 22:09 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 27,603 $13.92 $384,349.69
Disclosure

SEC source: 0001570562-24-000055 · wk-form4_1711058963.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 372,288

F1 · kind: The sales reported on this Form 4 were mandated by the Issuer pursuant to Restricted Stock Unit Agreements requiring the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction, and does not represent a discretionary trade by the reporting person.

F2 · price: The shares were sold in multiple trades at prices ranging from $13.555 to $14.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
February 22, 2024 Filed Feb 24, 2024 01:27 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 1,821 $13.08 $23,820.87
Disclosure

SEC source: 0001570562-24-000030 · wk-form4_1708738054.xml · nonDerivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 399,891

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the PSUs.

Read SEC document
February 21, 2024 Filed Feb 24, 2024 01:27 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 13,115 $0.00 $0.00
Disclosure

SEC source: 0001570562-24-000030 · wk-form4_1708738054.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 401,712

F1 · shares: Represents shares issuable on settlement of performance restricted stock units ("PSUs") granted to the reporting person in January 2023. The Issuer's Compensation Committee certified that the reporting person had achieved the set corporate development goal as of December 20, 2023. One-third of the PSU (4,372 shares) was delivered on February 21, 2024 after certification of the milestone being achieved. The remaining two-thirds will vest annually on the anniversary of December 20, 2023 provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 23:36 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 47,337 $0.00 Strike: $13.15 $0.00
Disclosure

SEC source: 0001570562-24-000017 · wk-form4_1707521755.xml · derivative · entry 3

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 47,337

Underlying: Common Stock · 47,337 shares

Expires 2034-02-07

F4 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 23:36 UTC Evolus, Inc. EOLS · Entity 5341 GrantPerformance Restricted Stock Units · Derivative 17,606 $0.00 $0.00
Disclosure

SEC source: 0001570562-24-000017 · wk-form4_1707521755.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,606

Underlying: Common Stock · 17,606 shares

Expires not disclosed

F2 · derivative.exercise_price: Each performance-based restricted stock unit (PSU) represents the right to receive, following vesting, a number of shares of common stock of the issuer up to 200% of the number of PSUs.

F3 · derivative.exercise_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 50% of the PSUs earned will vest on February 7, 2026 and the remaining 50% of the PSUs will vest on February 7, 2027, in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

F3 · derivative.expiration_date: The number of shares of Common Stock acquired upon vesting of the PSUs is contingent upon the achievement of a preestablished performance metrics, as approved by the Issuer's Compensation Committee, over a two-year performance period. Subject to the Issuer's compensation committee certifying the underlying performance metrics, 50% of the PSUs earned will vest on February 7, 2026 and the remaining 50% of the PSUs will vest on February 7, 2027, in each case subject to time based service requirements and continuous employment with the Issuer through the vesting dates.

Read SEC document
February 07, 2024 Filed Feb 9, 2024 23:36 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 35,211 $0.00 $0.00
Disclosure

SEC source: 0001570562-24-000017 · wk-form4_1707521755.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 388,597

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of February 7, 2024, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
August 16, 2023 Filed Aug 17, 2023 00:25 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 2,211 $10.27 $22,706.97
Disclosure

SEC source: 0001570562-23-000100 · wk-form4_1692231941.xml · nonDerivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 353,386

F2 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the PSUs.

Read SEC document
August 14, 2023 Filed Aug 17, 2023 00:25 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 19,672 $0.00 $0.00
Disclosure

SEC source: 0001570562-23-000100 · wk-form4_1692231941.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 355,597

F1 · shares: Represents shares issuable on settlement of performance restricted stock units ("PSUs") granted to the reporting person in January 2023. On August 14, 2023, the Issuer's Compensation Committee certified that the reporting person had achieved the set corporate development goal as of May 9, 2023. One-third of the PSU (6,557 shares) was vested and delivered immediately upon certification of the goal achievement. The remaining two-thirds will vest annually on the anniversary of May 9, 2023 provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
March 14, 2023 Filed Mar 16, 2023 23:01 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 14,906 $8.47 $126,237.42
Disclosure

SEC source: 0001570562-23-000045 · wf-form4_167900769866882.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 335,925

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $8.25 to $8.67. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 25, 2023 Filed Jan 28, 2023 00:25 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 85,670 $0.00 Strike: $11.04 $0.00
Disclosure

SEC source: 0001570562-23-000012 · wf-form4_167486549856245.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,670

Underlying: Common Stock · 85,670 shares

Expires 2033-01-25

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
January 25, 2023 Filed Jan 28, 2023 00:25 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 97,642 $0.00 $0.00
Disclosure

SEC source: 0001570562-23-000012 · wf-form4_167486549856245.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 350,831

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 25, 2023, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
March 08, 2022 Filed Mar 11, 2022 00:23 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 10,192 $9.73 $99,121.28
Disclosure

SEC source: 0001570562-22-000084 · wf-form4_164695819801702.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 253,189

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $9.50 to $9.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 24, 2022 Filed Jan 27, 2022 02:02 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 77,640 $0.00 Strike: $5.46 $0.00
Disclosure

SEC source: 0001570562-22-000053 · wf-form4_164324895584499.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 77,640

Underlying: Common Stock · 77,640 shares

Expires 2032-01-25

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
January 24, 2022 Filed Jan 27, 2022 02:02 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 53,571 $0.00 $0.00
Disclosure

SEC source: 0001570562-22-000053 · wf-form4_164324895584499.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 263,381

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 24, 2022, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
August 10, 2021 Filed Aug 12, 2021 22:45 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 14,293 $11.18 $159,788.59
Disclosure

SEC source: 0001570562-21-000155 · wf-form4_162880829149055.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 209,810

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the second quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $11.1762 to $11.31. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 27, 2021 Filed Feb 2, 2021 00:29 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0001570562-21-000018 · wf-form4_161222574461892.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 224,103

F1 · price: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 27, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
January 25, 2021 Filed Jan 27, 2021 01:50 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 2,699 $7.46 $20,134.54
Disclosure

SEC source: 0001570562-21-000010 · wf-form4_161171222211564.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 134,103

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the first quarter of 2020 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

Read SEC document
May 13, 2020 Filed May 16, 2020 00:00 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 40,000 $0.00 $0.00
Disclosure

SEC source: 0001570562-20-000094 · wf-form4_158958718809777.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 136,802

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest as to 100% of the award on July 1, 2021, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
January 23, 2020 Filed Jan 25, 2020 02:15 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 45,000 $0.00 Strike: $10.19 $0.00
Disclosure

SEC source: 0001570562-20-000049 · wf-form4_157991848930412.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2030-01-23

F2 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
January 23, 2020 Filed Jan 25, 2020 02:15 UTC Evolus, Inc. EOLS · Entity 5341 GrantCommon Stock 26,000 $0.00 $0.00
Disclosure

SEC source: 0001570562-20-000049 · wf-form4_157991848930412.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 96,802

F1 · shares: Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs will vest over a period of four years, with 1/4th of the RSU vesting annually on the anniversary of January 23, 2020, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document
January 07, 2020 Filed Jan 9, 2020 00:37 UTC Evolus, Inc. EOLS · Entity 5341 SaleCommon Stock 39,442 $10.71 $422,281.83
Disclosure

SEC source: 0001570562-20-000002 · wf-form4_157853021770409.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,802

F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in the fourth quarter of 2019 and represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of certain Restricted Stock Units.

F2 · price: The shares were sold in multiple trades at prices ranging from $10.68 to $11.2016. The price reported above reflects the weighted average selling price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.

Read SEC document
December 10, 2019 Filed Dec 11, 2019 22:53 UTC Evolus, Inc. EOLS · Entity 5341 Exercise / conversionStock Option (Right to Buy) · Derivative 10,020 $0.00 Strike: $9.98 $0.00
Disclosure

SEC source: 0001570562-19-000164 · wf-form4_157610476734295.xml · derivative · entry 2

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 189,682

Underlying: Common Stock · 10,020 shares

Expires 2028-01-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option was granted on January 6, 2018 for the right to buy 199,702 shares of common stock of the Issuer. The shares subject to the option vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 6, 2018, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including upon certain changes of control of the Issuer.

Read SEC document
December 10, 2019 Filed Dec 11, 2019 22:53 UTC Evolus, Inc. EOLS · Entity 5341 Exercise / conversionCommon Stock 10,020 $9.98 $99,999.60
Disclosure

SEC source: 0001570562-19-000164 · wf-form4_157610476734295.xml · nonDerivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,244

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 23, 2019 Filed Jan 26, 2019 01:22 UTC Evolus, Inc. EOLS · Entity 5341 GrantStock Option (Right to Buy) · Derivative 60,000 $0.00 Strike: $16.19 $0.00
Disclosure

SEC source: 0001570562-19-000026 · wf-form4_154846575247503.xml · derivative · entry 1

Avelar Rui · CIK 0001432063 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,000

Underlying: Common Stock · 60,000 shares

Expires 2029-01-23

F1 · derivative.exercise_date: The shares subject to the option will vest over a period of four years, with 1/4th of the shares subject to the option vesting annually on the anniversary of January 23, 2019, provided the reporting person remains in continuous service on each vesting date, subject to accelerated vesting in certain events, including certain terminations of the reporting person or upon certain changes of control of the issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.